AHCO Stock Analysis: Buy, Sell, or Hold?
AHCO - AdaptHealth Corp. Common Stock
$9.66
0.01 (0.10%)
▲
5d:
-4.92%
30d:
-7.82%
90d:
-2.52%
BUY
HIGH Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Smart Money Distribution
None View Scanner →
Strength: 5.6/10
Get Alerted When AHCO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: AHCO trading at deep discount. Market pricing in -4.6% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: AHCO trading at deep discount. Market pricing in -4.6% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$21.75
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$13.51
28.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AHCO is currently trading at $9.66, which is considered oversold relative to its 30-day fair value range of $9.76 to $10.68. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.2) compared to its historical average (9.5). Remarkably, the market is currently pricing in an annual earnings decline of 4.6% over the next few years. This pessimistic expectation contrasts with the company's recent 6.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, AHCO is in a uptrend. The price is currently testing key support at $9.45. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.00 (+44.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AHCO is in a uptrend. The price is currently testing key support at $9.45. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.00 (+44.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$9.76 -
$10.68
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 44.9% below Wall St target ($14.00)
Trading Range Analysis
30-Day Trading Range
$9.76 -
$10.68
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$9.45
Resistance Level
$10.43
Current Trend
Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.22
Wall Street Target
$14.00
(+44.9%)
Revenue Growth (YoY)
5.4%
Earnings Growth (YoY)
6.7%
Profit Margin
-2.4%
Valuation Discount vs History
-4.6% cheaper
PE vs Historical
8.2 vs 9.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.6%
(market-implied from PE analysis)
1-Year Target
$9.22
(-5%)
2-Year Target
$8.79
(-9%)
3-Year Target
$8.39
(-13%)
3-Yr Target (if PE normalizes)
(PE: 8→10)
$9.70
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 39.9%)
$70.06
(+625%)
Base:
(SPY PE: 8.2, Growth: 39.9%)
$26.43
(+174%)
Bear:
(PE: 7.0, Growth: 39.9%)
$22.46
(+133%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.2 to 9.5
Stabilization Target:
$11.17
(+15.6%)
PE Expansion Potential:
+15.6%
Share & Embed Analysis
Last updated: June 23, 2026 9:21 AM ET
Data refreshes hourly during market hours. Next update: 10:21 AM
Data refreshes hourly during market hours. Next update: 10:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AHCO showing a specific setup today?
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Richard M Cashin Jr
BUY
447100 shares
2026-03-20
Richard M Cashin Jr
BUY
727 shares
2026-03-19
Richard M Cashin Jr
BUY
689336 shares
2026-03-12
Featured in Portfolios
AHCO is a key holding in these high-performance investment strategies.
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 52 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 60 HOLD |
Advanced AHCO Option Strategies
Professional options setups generated by AI based on today's AHCO price and gamma walls.
